Medallion vs Verisys
Two Credentialing & Provider Data vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Medallion | Verisys | |
|---|---|---|
| Pricing model | Enterprise contract (custom) · Priced by provider count and modules | Enterprise contract (custom) · Per-file and subscription components, quoted |
| Speed to go live | SaaS onboarding in weeks, no EHR project | Standard onboarding project; delegated credentialing takes longer |
| Automation model | Tech-enabled service · Automation plus credentialing operations team | Tech-enabled service · Data platform plus human CVO staff |
| Built for | Mid-size groups, Enterprise systems, Payers | Enterprise systems, Payers |
| Security posture | SOC 2 Type II | SOC 2 Type II, ISO 27001, HIPAA |
| Company maturity | 6 yrs (est. 2020) | 34 yrs (est. 1992) |
| Financial backing | $130M · Series C+ | Private equity backed |
| Named customers | 5 named | 1 named |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 2 listed | 4 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick Medallion if you want licensing, credentialing, and payer enrollment taken off your team's plate by one NCQA-certified vendor.
- Pick Verisys if you need a large, audit-proven outsourced CVO with its own sanctions database rather than credentialing software to run yourself.
Medallion
Credentialing, licensing, and enrollment on one platform
- Founded
- 2020
- HQ
- San Francisco, CA
- Stage
- Series C+
- Raised
- $130M
What it does
- Automates state licensing applications and renewals
- Credentialing with primary source verification
- Payer enrollment across commercial and government plans
- Continuous monitoring for sanctions and expirables
- CredAlliance clearinghouse shares credentialing across payers
- Single system of record for provider data
Where it's strong
- Broadest scope in the category, covering licensing, credentialing, enrollment, and monitoring in one platform, which cuts vendor sprawl.
- Well capitalized at $130M with brand-name investors and 250+ customers, so vendor risk is lower than most peers.
- Strong fit for multi-state telehealth and fast-scaling groups that need licensing and enrollment handled together.
What buyers should weigh
- Much of the work is service-backed rather than pure software, so outcomes depend on Medallion's ops team; get turnaround SLAs in writing.
- Pricing is per-provider and per-service, and enrollment is typically priced separately from credentialing, so total cost climbs with scope.
- CredAlliance launched in August 2025 and its payer network effects are still unproven.
Named customers
Tampa General Hospital · Carbon Health · Hims · Headspace · Oak Street Health
Integrations
Verisys
National CVO for provider verification, screening, and monitoring
- Founded
- 1992
- HQ
- Louisville, KY
- Stage
- Private equity backed
- Raised
- n/a
What it does
- Primary source verification for NCQA-accredited credentialing
- FACIS sanctions and exclusions screening database
- Continuous license and OIG exclusion monitoring
- Full outsourced CVO services at national scale
- Provider identity verification with ID.me for Medicaid
- Payer enrollment and network compliance support
Where it's strong
- One of the largest outsourced CVOs, so it handles enterprise volume that smaller shops cannot.
- Owns its own screening database (FACIS) instead of reselling third-party data.
- Long compliance track record with NCQA-oriented processes and ISO certification.
What buyers should weigh
- A 30-year-old services-heavy company, not a modern self-serve software product.
- Multiple acquisitions and rebrands (Aperture, Med Advantage) can mean uneven tooling across product lines.
- Pricing and contracts are enterprise-style and opaque; small groups may find lighter options cheaper.
Named customers
MedCost
Integrations
Compare against the rest of Credentialing & Provider Data
Deciding between these two?
First Pass tracks Credentialing & Provider Data every week: funding, launches, and what changed since this page was written.